1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Acromegaly Global Clinical Trials Review, H1, 2014

Acromegaly Global Clinical Trials Review, H1, 2014

  • May 2014
  • -
  • Global Data
  • -
  • 116 pages

Acromegaly Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Acromegaly Global Clinical Trials Review, H1, 2014" provides data on the Acromegaly clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acromegaly. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acromegaly. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Acromegaly Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Acromegaly 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acromegaly to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acromegaly to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Acromegaly 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Acromegaly Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Acromegaly 33
Apr 22, 2014: Aspireo Reports Data in Further Phase Ib Study 33
Mar 21, 2014: ATL1103 Acromegaly Phase II Trial Recruitment Completed 33
Dec 23, 2013: Positive Results Achieved from Interim Analysis of ATL1103 Phase II Trial 34
Nov 26, 2013: ATL1103 Phase II Trial Update 35
Oct 17, 2013: ATL1103 Phase II Trial Update - Interim Analysis 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Ipsen S.A. 38
Clinical Trial Overview of Ipsen S.A. 38
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Pfizer Inc. 42
Clinical Trial Overview of Pfizer Inc. 42
Endo International plc 43
Clinical Trial Overview of Endo International plc 43
Aspireo Pharmaceuticals Ltd. 44
Clinical Trial Overview of Aspireo Pharmaceuticals Ltd. 44
Ambrilia Biopharma Inc. 45
Clinical Trial Overview of Ambrilia Biopharma Inc. 45
Glide Pharmaceutical Technologies Limited 46
Clinical Trial Overview of Glide Pharmaceutical Technologies Limited 46
Camurus AB 47
Clinical Trial Overview of Camurus AB 47
Antisense Therapeutics Limited 48
Clinical Trial Overview of Antisense Therapeutics Limited 48
Chiasma, Inc. 49
Clinical Trial Overview of Chiasma, Inc. 49
Clinical Trial Overview of Top Institutes / Government 50
Cedars-Sinai Medical Center 50
Clinical Trial Overview of Cedars-Sinai Medical Center 50
Aarhus University 51
Clinical Trial Overview of Aarhus University 51
The Federico II University 52
Clinical Trial Overview of The Federico II University 52
Massachusetts General Hospital 53
Clinical Trial Overview of Massachusetts General Hospital 53
Erasmus MC 54
Clinical Trial Overview of Erasmus MC 54
Barts and The London NHS Trust 55
Clinical Trial Overview of Barts and The London NHS Trust 55
National Center for Research Resources 56
Clinical Trial Overview of National Center for Research Resources 56
The National Institute of Diabetes and Digestive and Kidney Diseases 57
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 57
Herlev Hospital 58
Clinical Trial Overview of Herlev Hospital 58
Columbia University 59
Clinical Trial Overview of Columbia University 59
Five Key Clinical Profiles 60
Appendix 114
Abbreviations 114
Definitions 114
Research Methodology 115
Secondary Research 115
About GlobalData 116
Contact Us 116
Disclaimer 116
Source 116

List of Tables
Acromegaly Therapeutics, Global, Clinical Trials by Region, 2014* 7
Acromegaly Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acromegaly Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acromegaly Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Acromegaly Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Acromegaly Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Acromegaly Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Acromegaly Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Acromegaly to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Acromegaly Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acromegaly Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acromegaly to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Acromegaly Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acromegaly Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acromegaly Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Acromegaly Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Acromegaly Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Acromegaly Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acromegaly Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Acromegaly Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Acromegaly Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Acromegaly Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Acromegaly Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Acromegaly Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Acromegaly Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acromegaly Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014* 38
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 40
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 42
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014* 43
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Aspireo Pharmaceuticals Ltd., 2014* 44
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Ambrilia Biopharma Inc., 2014* 45
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Glide Pharmaceutical Technologies Limited, 2014* 46
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Camurus AB, 2014* 47
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Antisense Therapeutics Limited, 2014* 48
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiasma, Inc., 2014* 49
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2014* 50
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 51
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by The Federico II University, 2014* 52
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 53
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 54
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Barts and The London NHS Trust, 2014* 55
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 56
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 57
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2014* 58
Acromegaly Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014* 59

List of Figures
Acromegaly Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Acromegaly Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acromegaly Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acromegaly Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Acromegaly Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Acromegaly Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Acromegaly Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Acromegaly Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Acromegaly to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Acromegaly Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acromegaly Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acromegaly to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Acromegaly Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acromegaly Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acromegaly Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Acromegaly Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Acromegaly Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Acromegaly Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acromegaly Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Acromegaly Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Acromegaly Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Acromegaly Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Acromegaly Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 115

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.